The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Antidepressants for the treatment of depression in people with cancer
Open accessAbstract
BACKGROUND: Major depression and other depressive conditions are common in people with cancer. These conditions are not easily detectable in clinical practice, due to the overlap between medical and psychiatric symptoms, as described by diagnostic manuals such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) and International Classification of Diseases (ICD). Moreover, it is particularly challenging to distinguish between pathological and normal reactions to such a severe illness. Depressive symptoms, even in subthreshold manifestations, have been shown to have a negative impact in terms of quality of life, compliance with anti-cancer treatment, suicide risk and likely even the mortality rate for the cancer itself. Randomised controlled trials (RCTs) on the efficacy and tolerability of antidepressants in this population group are few and often report conflicting results. OBJECTIVES: To assess the effects and acceptability of antidepressants for treating depressive symptoms in adults (18 years or older) with cancer (any site and stage). SEARCH METHODS: We searched the following electronic bibliographic databases: the Cochrane Central Register of Controlled Trials (CENTRAL 2014, Issue 3), MEDLINE Ovid (1946 to April week 3, 2014), EMBASE Ovid (1980 to 2014 week 17) and PsycINFO Ovid (1987 to April week 4, 2014). We additionally handsearched the trial databases of the most relevant national, international and pharmaceutical company trial registers and drug-approving agencies for published, unpublished and ongoing controlled trials. SELECTION CRITERIA: We included RCTs allocating adults (18 years or above) with any primary diagnosis of cancer and depression (including major depressive disorder, adjustment disorder, dysthymic disorder or depressive symptoms in the absence of a formal diagnosis) comparing antidepressants versus placebo, or antidepressants versus other antidepressants. DATA COLLECTION AND ANALYSIS: Two review authors independently checked eligibility and extracted data using a form specifically designed for the aims of this review. The two authors compared the data extracted and then entered data into RevMan 5 with a double-entry procedure. Information extracted included study and participant characteristics, intervention details, outcome measures for each time point of interest, cost analysis and sponsorship by a drug company. We used the standard methodological procedures expected by The Cochrane Collaboration. MAIN RESULTS: We retrieved a total of nine studies (861 participants), with seven studies contributing to the meta-analysis for the primary outcome. Four of these compared antidepressants and placebo, two compared two antidepressants and one-three armed study compared two antidepressants and a placebo arm. For the acute phase treatment response (6 to 12 weeks), we found very low quality evidence for the effect of antidepressants as a class on symptoms of depression compared with placebo when measured as a continuous outcome (standardised mean difference (SMD) -0.45, 95% confidence interval (CI) -1.01 to 0.11, five RCTs, 266 participants) or as a proportion of people who had depression (risk ratio (RR) 0.82, 95% CI 0.62 to 1.08, five RCTs, 417 participants). No trials reported data on the follow-up response (more than 12 weeks). In head-to-head comparisons we only retrieved data for selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants, providing very low quality evidence for the difference between these two classes (SMD -0.08, 95% CI -0.34 to 0.18, three RCTs, 237 participants). No clear evidence of an effect of antidepressants versus either placebo or other antidepressants emerged from the analyses of the secondary efficacy outcomes (dichotomous outcome, response at 6 to 12 weeks, very low quality evidence). We found very low quality evidence for the effect of antidepressants as a class in terms of dropouts due to any cause compared with placebo (RR 0.87, 95% CI 0.49 to 1.53, six RCTs, 455 participants), as well as between SSRIs and tricyclic antidepressants (RR 0.83, 95% CI 0.53 to 1.30, three RCTs, 237 participants). We downgraded the quality of the evidence because the included studies were at an unclear or high risk of bias due to poor reporting, imprecision arising from small sample sizes and wide confidence intervals, and inconsistency due to statistical or clinical heterogeneity. AUTHORS' CONCLUSIONS: Despite the impact of depression on people with cancer, available studies were very few and of low quality. This review found very low quality evidence for the effects of these drugs compared with placebo. On the basis of these results clear implications for practice cannot be made. The use of antidepressants in people with cancer should be considered on an individual basis and, considering the lack of head-to-head data, the choice of which agent should be prescribed may be based on the data on antidepressant efficacy in the general popula
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Psychotherapy for depression among incurable cancer patients
Akechi, T., Okuyama, T., Onishi, J., Morita, T., & Furukawa, T. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005537.pub2 · Cited by 198
RetractedAaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Publication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282
Research works printed but not linked: 91
- Fisch, 2003, Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group, Journal of Clinical Oncology, 21, 1937, 10.1200/JCO.2003.08.025 · DOI · Paper page
- Holland, 1998, A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer, Psycho-oncology, 7, 291-300, 10.1002/(SICI)1099-1611(199807/08)7:4<291::AID-PON361>3.0.CO;2-U · DOI · Paper page
- Musselman, 2006, A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression, Journal of Clinical Psychiatry, 67, 288, 10.4088/JCP.v67n0217 · DOI
- Navari, 2008, Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy, Breast Cancer Research and Treatment, 112, 197-201, 10.1007/s10549-007-9841-z · DOI
- Pezzella, 2001, Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline, Breast Cancer Research and Treatment, 70, 1, 10.1023/A:1012518831494 · DOI
- Razavi, 1996, The effect of fluoxetine on anxiety and depression symptoms in cancer patients, Acta Psychiatrica Scandinavica, 94, 205, 10.1111/j.1600-0447.1996.tb09850.x · DOI · Paper page
- Heeringen, 1996, Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin, British Journal of Psychiatry, 69, 440, 10.1192/bjp.169.4.440 · DOI
- Amodeo, 2012, Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study, Support Care Cancer, 20, 375-84, 10.1007/s00520-011-1118-8 · DOI
- Biglia, 2005, Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors, Maturitas, 52, 78, 10.1016/j.maturitas.2005.01.001 · DOI
- Biglia, 2009, Duloxetine and escitalopram for treatment of hot flushes in breast cancer survivors, Maturitas, 63, S34, 10.1016/S0378-5122(09)70131-8 · DOI
- Boekhout, 2011, Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial, Journal of Clinical Oncology, 29, 3862, 10.1200/JCO.2010.33.1298 · DOI
- Caldera, 2009, Algorithm-based treatment for depression in cancer outpatients: efficacy and tolerability evaluation of newer antidepressants, Psycho-oncology, 18, S317, 10.1002/pon.1594 · DOI
- Cankurtaran, 2008, Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine, Supportive Care in Cancer, 16, 1291, 10.1007/s00520-008-0425-1 · DOI
- Carmen, 1990, Amitriptilin as coanalgesic in cancerous patients, Salud Mental, 13, 1
- Ell, 2010, Collaborative depression treatment in older and younger adults with physical illness: pooled comparative analysis of three randomized clinical trials, American Journal of Geriatric Psychiatry, 18, 520, 10.1097/JGP.0b013e3181cc0350 · DOI
- Evans, 1988, Treatment of depression in cancer patients is associated with better life adaptation: a pilot study, Psychosomatic Medicine, 50, 72, 10.1097/00006842-198801000-00009 · DOI
- Heras, 2013, The role of paroxetine in fatigue and depression of patients under chemotherapeutic treatment, American Journal of Therapeutics, 20, 254-6, 10.1097/MJT.0b013e318187de2c · DOI
- Hua, 2009, Investigation and intervening therapy to depression of malignant hematological diseases Baixuebing, Linbaliu, Baixuebing, Linbaliu [Journal of Leukaemia and Lymphoma], 18, 432
- Montgomery C (contact name) A randomized controlled trial of venlafaxine versus placebo for depression amongst persons with lymphoma or leukaemia International Standard Randomised Controlled Trial Number Register 2003 10.1186/ISRCTN51232664 · doi:10.1186/isrctn51232664
- Kalso, 1996, Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer, Pain, 64, 293, 10.1016/0304-3959(95)00138-7 · DOI · Paper page
- Kamath, 2010, A randomized, double-blind placebo-controlled study evaluating the efficacy of Lovaza (omega-3-acid-ethyl esters) compared to placebo for the treatment of depressive and anxiety symptoms in patients with breast cancer, Psycho-oncology, 19, s269, 10.1002/pon.1776 · DOI
- Kautio, 2008, Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms, Journal of Pain and Symptom Management, 35, 31, 10.1016/j.jpainsymman.2007.02.043 · DOI · Paper page
- Kimmick, 2006, Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen, The Breast Journal, 12, 114, 10.1111/j.1075-122X.2006.00218.x · DOI · Paper page
- Loibl, 2007, Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients-a double-blind, randomized study, Annals of Oncology, 18, 689-93, 10.1093/annonc/mdl478 · DOI
- Lydiatt, 2008, A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer, Otolaryngology--Head and Neck Surgery, 134, 528, 10.1001/archotol.134.5.528 · DOI
- Marasanov, 2013, Pharmacological correction of emotional status in breast cancer patients in the postoperative period, ВОПРОСЫ онкологии (Oncology Questions), 59, 95
- Musselman, 2013, The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings, Neuropsychopharmacology, 38, 1921, 10.1038/npp.2013.85 · DOI
- Nunez, 2013, Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial, Journal of Pain and Symptom Management, 45, 969, 10.1016/j.jpainsymman.2012.06.011 · DOI
- Palesh, 2012, Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program, Sleep Medicine, 13, 1184, 10.1016/j.sleep.2012.06.001 · DOI
- Panerai, 1990, A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain, Acta Neurologica Scandinavica, 82, 34, 10.1111/j.1600-0404.1990.tb01584.x · DOI
- Rodríguez Vega, 2011, Combined therapy versus usual care for the treatment of depression in oncologic patients: a randomized controlled trial, Psycho-oncology, 20, 943, 10.1002/pon.1800 · DOI
- Roscoe, 2005, Effect of paroxetine hydrochloride (Paxilò) on fatigue and depression in breast cancer patients receiving chemotherapy, Breast Cancer Research and Treatment, 89, 243, 10.1007/s10549-004-2175-1 · DOI · Paper page
- Stockler, 2007, Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression:a placebo-controlled double-blind randomised trial, Lancet Oncology, 8, 603, 10.1016/S1470-2045(07)70148-1 · DOI
- Taraz, 2013, Sertraline decreases serum level of interleukin-6 (IL-6) in haemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial, International Immunopharmacology, 17, 917, 10.1016/j.intimp.2013.09.020 · DOI
- Theobald, 2002, An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms, Journal of Pain and Symptom Management, 23, 442, 10.1016/S0885-3924(02)00381-0 · DOI · Paper page
- Tondlova, 1997, Citalopram in the treatment of depression in patients suffering from simultaneous serious somatic disorders, European Neuropsychopharmacology, 7, 188, 10.1016/S0924-977X(97)88616-6 · DOI
- Tondlová, 2002, Citalopram and dosulepine in adjuvant treatment of oncological pain, Bolest, 4
- Zhang, 2003, Paroxetine in treatment of cancer patients with anxiety and depression, Zhongguo zin li wei sheng za zhi (Chinese Mental Health Journal), 17, 482
- Zhang, 2011, Preliminary study of association between breast cancer and depression, Tumor, 31, 457, 10.3781/j.issn.1000-7431.2011.05.015 · doi:10.3781/j.issn.1000-7431.2011.05.015
- Zvukova, 2011, Pharmacological correction of psychoemotional states of patients with thyroid nodules in the preoperative period, Russian Journal of Medicine, 3c, 31
- Yi Ba Mirtazapine plus gemcitabine versus gemcitabine in metastasis pancreatic cancer ClincalTrials.gov 2012 · doi:10.1016/j.ysur.2011.08.015
- Anderson, 2000, Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines, Journal of Psychopharmacology (Oxford, England), 14, 3, 10.1177/026988110001400101 · DOI · Paper page
- Andrade, 2012, Breast cancer and antidepressant use, Journal of Clinical Psychiatry, 73, e1156, 10.4088/JCP.12f08054 · DOI
- American Psychiatric Association, 1980, Diagnostic and Statistical Manual of Mental Disorders (DSM-III)
- American Psychiatric Association, 1987, Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
- American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
- Arrieta, 2013, Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer, Annals of Surgical Oncology, 20, 1941, 10.1245/s10434-012-2793-5 · DOI · Paper page
- Barbui, 2001, Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials, British Journal of Psychiatry, 178, 129, 10.1192/bjp.178.2.129 · DOI · Paper page
- Barbui, 2011, Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis, British Journal of Psychiatry, 198, 11, 10.1192/bjp.bp.109.076448 · DOI · Paper page
- Beck, 1961, An inventory for measuring depression, Archives of General Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
- Brenne, 2013, Depressed patients with incurable cancer: which depressive symptoms do they experience?, Palliative and Supportive Care, 11, 491, 10.1017/S1478951512000909 · DOI
- Galway, 2012, Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007064.pub2 · DOI · Paper page
- Hamilton, 1960, A rating scale for depression, Journal of Neurology, Neurosurgery and Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Hart, 2012, Meta-Analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer, Journal of the National Cancer Institute, 104, 990, 10.1093/jnci/djs256 · DOI · Paper page
- Henry, 1995, Relative mortality from overdose of antidepressants, BMJ, 310, 221, 10.1136/bmj.310.6974.221 · DOI · Paper page
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Iovieno, 2011, Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials, International Clinical Psychopharmacology, 26, 69, 10.1097/YIC.0b013e328340775e · DOI
- Irwin, 2013, Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes, Current Psychiatry Reports, 15, 404, 10.1007/s11920-013-0404-1 · DOI · Paper page
- Kathol, 1981, Relationship of depression to medical illness. A critical review, Journal of Affective Disorders, 3, 111, 10.1016/0165-0327(81)90036-7 · DOI
- Kelly, 2010, Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study, BMJ, 340, 1, 10.1136/bmj.c693 · DOI · Paper page
- Kim, 2010, Quality of life of family caregivers at 2 years after a relative's cancer diagnosis, Psycho-oncology, 19, 431, 10.1002/pon.1576 · DOI
- Laoutidis, 2013, Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis, BMC Psychiatry, 13, 1, 10.1186/1471-244X-13-140 · DOI
- Lapidus, 2013, Novel glutamatergic drugs for the treatment of mood disorders, Neuropsychiatric Disease and Treatment, 9, 1101, 10.2147/NDT.S36689 · DOI
- Lloyd-Williams, 2009, Depression - an independent predictor of early death inpatients with advanced cancer, Journal of Affective Disorders, 113, 127, 10.1016/j.jad.2008.04.002 · DOI
- Lopresti, 2012, Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects, Journal of Psychopharmacology, 26, 1512, 10.1177/0269881112458732 · DOI
- Mottram, 2009, Antidepressants for depressed elderly, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003491.pub2 · DOI · Paper page
- Onitilo, 2006, Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site, General Hospital Psychiatry, 28, 396, 10.1016/j.genhosppsych.2006.05.006 · DOI · Paper page
- Pilar-Cuéllar, 2013, Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication, Neural Plasticity, 2013, 1, 10.1155/2013/537265 · DOI
- Prieto, 2002, Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation, Journal of Clinical Oncology, 20, 1907, 10.1200/JCO.2002.07.101 · DOI · Paper page
- Raison, 2003, Depression in cancer: new developments regarding diagnosis and treatment, Biological Psychiatry, 54, 283-94, 10.1016/S0006-3223(03)00413-X · DOI · Paper page
- Rayner, 2010, Antidepressants for depression in physically ill people, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007503.pub2 · DOI · Paper page
- Rayner, 2011, Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis, Palliative Medicine, 25, 36, 10.1177/0269216310380764 · DOI · Paper page
- Rayner, 2011, The development of evidence-based European guidelines on the management of depression in palliative cancer care, European Journal of Cancer, 47, 702, 10.1016/j.ejca.2010.11.027 · DOI
- Riblet, 2014, Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis, General Hospital Psychiatry, 36, 466, 10.1016/j.genhosppsych.2014.05.010 · DOI · Paper page
- Rodin, 2007, The treatment of depression in cancer patients: a systematic review, Supportive Care in Cancer, 15, 123, 10.1007/s00520-006-0145-3 · DOI · Paper page
- Rooney, 2010, Pharmacological treatment of depression in patients with a primary brain tumour, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006932.pub2 · DOI
- Rooney, 2013, Pharmacological treatment of depression in patients with a primary brain tumour, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006932.pub3 · DOI
- Sarubin, 2014, Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression, Psychoneuroendocrinology, 39, 141, 10.1016/j.psyneuen.2013.10.008 · DOI
- Shelton, 2007, The molecular neurobiology of depression, Psychiatric Clinics of North America, 30, 1, 10.1016/j.psc.2006.12.005 · DOI · Paper page
- Shim, 2012, Suicidality and its associated factors in cancer patients: results of a multi-center study in Korea, International Journal of Psychiatry in Medicine, 43, 381, 10.2190/PM.43.4.g · DOI
- Silva de Lima, 1999, The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis, Psychological Medicine, 29, 1273, 10.1017/S0033291799001324 · DOI
- Silva de Lima, 2005, Drugs versus placebo for dysthymia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001130 · DOI
- Stewart, 1965, Depression among medically ill patients, Diseases of the Nervous System, 26, 479
- Vergouwen, 2003, Improving adherence to antidepressants: a systematic review of interventions, Journal of Clinical Psychiatry, 64, 1415, 10.4088/JCP.v64n1203 · DOI · Paper page
- Walker, 2014, Treatment of depression in adults with cancer: a systematic review of randomized controlled trials, Psychological Medicine, 44, 897, 10.1017/S0033291713001372 · DOI
- Wang, 2011, Effects of psychological interventions in cancer patients undergoing radiotherapy, Chinese Journal of Clinical Psychology, 19, 561
- Ware JB Brook RH Williams KN Stewart AL Davies-Avery A Conceptualisation and measurement of health for adults in the health insurance study Model of Health and Methodology 1980 · DOI
- Ware, 1992, The MOS 36-item short-form health survey (SF-36) 1: conceptual framework and item selection, Medical Care, 30, 473, 10.1097/00005650-199206000-00002 · DOI · Paper page
- WHO, 1978, The Ninth Revision of the International Classification of Diseases and Related Health Problems (ICD-9)
- WHO, 1992, The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10)
- Zigmond, 1983, The Hospital Anxiety and Depression Scale, Acta Psychiatrica Scandinavica, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x · DOI · Paper page
Cited by
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Riba, M. B., Donovan, K. A., Andersen, B., Braun, I., Breitbart, W. S., Brewer, B. W., Buchmann, L. O., Clark, M. M., Collins, M., Corbett, C., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0048 · Cited by 871
Niedzwiedz, C. L., Knifton, L., Robb, K. A., Katikireddi, S. V., & Smith, D. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-6181-4 · Cited by 756
Comorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
Metadata
- Authors
- Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-06-01
- Volume
- 4
- Issue
- 6
- Pages
- CD011006-CD011006
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1659048389
- Cited by
- 183
- References
- 39
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Update notices
- new_version (2018-04-23)
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressants for the treatment of depression in people with cancer. https://app.cochat.ai/papers/10.1002/14651858.cd011006.pub2
- The paper
- Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. (2015). Antidepressants for the treatment of depression in people with cancer. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd011006.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.